搜尋結果
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 6 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 6 日前, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 7 日前... Commission on Tuesday said it is challenging hundreds of alleged "junk" patents ...